Ticker Details
Janux Therapeutics, Inc.
IPO Date:	June 11, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.02B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.88 | 3.80%
Avg Daily Range (30 D):	$0.28 | 1.97%
Avg Daily Range (90 D):	$0.28 | 1.95%

Institutional Daily Volume
Avg Daily Volume:	.48M
Avg Daily Volume (30 D):	1.01M
Avg Daily Volume (90 D):	.89M

Trade Size
Avg Trade Size (Sh.):	69
Avg Trade Size (Sh.) (30 D):	66
Avg Trade Size (Sh.) (90 D):	60

Institutional Trades
Total Institutional Trades:	1,834
Avg Institutional Trade:	$2.17M
Avg Institutional Trade (30 D):	$1.91M
Avg Institutional Trade (90 D):	$2.02M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.24M
Avg Closing Trade (30 D):	$2.79M
Avg Closing Trade (90 D):	$2.49M
Avg Closing Volume:	120.68K

News

Jan 22, 2026 @ 7:02 PM Janux Therapeutics Strikes Bristol Myers Biotech D... Source: Vandana Singh

Dec 4, 2024 @ 11:23 PM Why Janux Therapeutics Crushed the Market Today Source: Eric Volkman

May 30, 2024 @ 3:01 PM The Latest Analyst Ratings For Janux Therapeutics Source: Benzinga Insights

May 13, 2024 @ 1:00 PM Analyst Ratings For Janux Therapeutics Source: Benzinga Insights

May 7, 2024 @ 12:15 PM Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Los... Source: Zacks Equity Research

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-1.84	$-.39	$-.51
Diluted EPS	$-1.84	$-.39	$-.51
Revenue	$13.73M	$3.73M	$M
Gross Profit
Net Income / Loss	$-114.48M	$-24.36M	$-31.95M
Operating Income / Loss	$-156.98M	$-34.21M	$-42.4M
Cost of Revenue
Net Cash Flow	$-21.92M	$-.51M	$3.95M
PE Ratio